Skip to main content
. 2018 May 8;11:179–192. doi: 10.2147/JIR.S141033

Table 2.

Potential biomarkers in peripheral blood for antidepressant-treatment outcomes

Cytokine Serum level of cytokine in MDD vs controls Results of treatment outcome Reference(s)
IL6 Baseline increased Resistant to treatment 8385
Increased Significantly reduced by escitalopram and nortriptyline 86
Escitalopram had no effect 87
Increased Fluoxetine had no effect 88
IL11 No known difference Reduced by escitalopram 87
IL1β Increased Significantly reduced by escitalopram and nortriptyline 86
No change with 8 weeks’ escitalopram 87
TNF Baseline increased Poor response to amitriptyline 8
Baseline increased Poor response to SSRIs 16, 89
Baseline increased Serum levels negatively correlated with response 84, 89

Abbreviations: MDD, major depressive disorder; SSRI, selective serotonin-reuptake inhibitor.